Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL21840

CCn1c(=NN=c2sc3cc(S(=O)(=O)O)ccc3n2CC)sc2cc(S(=O)(=O)O)ccc21.N.N

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.47
NPSR1 Q6W5P4 8/20 0.42
ALDH1A1 P00352 7/20 0.42
TSHR P16473 3/20 0.42
PKM P14618 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.40
KDM4E B2RXH2 6/20 0.39
NPC1 O15118 1/20 0.39
RECQL P46063 1/20 0.39
RAB9A P51151 1/20 0.39
PPARG P37231 1/20 0.38
NCOA2 Q15596 1/20 0.38
NCOA1 Q15788 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
MAPK1 P28482 1/20 0.38
HPGD P15428 4/20 0.37
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
GAA P10253 2/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL2319900 1.00 MAPT (0.47) MAPTNPSR1ALDH1A1TSHRPKM
Ammonia Solution, Strong SCHEMBL668709 1.00 MAPT (0.47) MAPTNPSR1ALDH1A1TSHRPKM
Ammonia Solution, Strong SCHEMBL306103 1.00 MAPT (0.47) MAPTNPSR1ALDH1A1TSHRPKM
Ammonia Solution, Strong SCHEMBL21839 1.00 MAPT (0.47) MAPTNPSR1ALDH1A1TSHRPKM
Ammonia Solution, Strong SCHEMBL1883384 1.00 MAPT (0.47) MAPTNPSR1ALDH1A1TSHRPKM
SCHEMBL432548 0.99 MAPT (0.48) MAPTNPSR1ALDH1A1TSHRPKM
SCHEMBL13458992 0.99 MAPT (0.48) MAPTNPSR1ALDH1A1TSHRPKM
SCHEMBL63297 0.99 MAPT (0.48) MAPTNPSR1ALDH1A1TSHRPKM
SCHEMBL14599149 0.99 MAPT (0.48) MAPTNPSR1ALDH1A1TSHRPKM
SCHEMBL7915441 0.99 MAPT (0.48) MAPTNPSR1ALDH1A1TSHRPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260016452-A1 CHEMICAL HYDROGEN PEROXIDE INDICATOR SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) 2026-01-15 US claimed
EP-4677362-A1 ENZYME LINKED IMMUNOASSAY WITH DIFFUSION RATE LIMITING MEDIUM Elleon Biotech Limited (HK) 2026-01-14 EP claimed
US-12435432-B2 Bismuth-based modified electrode, manufacturing method thereof and use thereof NATIONAL CHENG KUNG UNIVERSITY (TW) 2025-10-07 US claimed
WO-2025062323-A1 ENZYME LINKED IMMUNOASSAY WITH DIFFUSION RATE LIMITING MEDIUM ELLEON BIOTECH LIMITED (CN) 2025-03-27 WO claimed
WO-2025032060-A1 CRISPR-COACERVATE SYSTEM ETH ZURICH (CH) 2025-02-13 WO claimed
US-20250052746-A1 DIAGNOSTIC ASSAY USING MAGNETIC PARTICLES Osler Diagnostics Limited (GB) 2025-02-13 US claimed
EP-4506464-A1 CRISPR-COACERVATE SYSTEM ETH Zurich (CH) 2025-02-12 EP claimed
EP-4467163-A2 SELF INDICATING ANTIMICROBIAL CHEMISTRY Ecolab USA Inc. (US) 2024-11-27 EP claimed
EP-4453567-A1 DIAGNOSTIC ASSAY USING MAGNETIC PARTICLES Osler Diagnostics Limited (GB) 2024-10-30 EP claimed
US-20240302287-A1 WHITE NANOZYME TEST STRIP AND ITS PREPARATION METHOD AND APPLICATION QINGDAO AGRICULTURAL UNIVERSITY (CN) 2024-09-12 US claimed
WO-2015185504-A1 LIQUID CRYSTAL BIOSENSORS ETH ZURICH (CH) 2015-12-10 WO claimed
EP-2258714-B1 IMPROVED ANALYTICAL METHOD FOR THE DETECTION OF OCCULT HEPATITIS C AND CORRESPONDING DIAGNOSIS KIT FUNDACIÓN PARA EL ESTUDIO DE LAS HEPATITIS VIRALES (ES) 2015-02-25 EP claimed
EP-2815238-A2 A PROCESS FOR DETECTION AND OPTIONAL QUANTIFICATION OF AN ANALYTE Biocon Limited (IN) 2014-12-24 EP claimed
WO-2014152673-A1 QUANTITATIVE ASSESSMENT FOR CAP EFFICIENCY OF MESSENGER RNA SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2014-09-25 WO claimed
WO-2013121368-A2 A PROCESS FOR DETECTION AND OPTIONAL QUANTIFICATION OF AN ANALYTE BIOCON LIMITED (IN) 2013-08-22 WO claimed
WO-2011149233-A2 MAGNETIC-NANOPARTICLE/PLATINUM-NANOPARTICLE/POROUS-CARBON COMPOSITE AND METHOD FOR PREPARING SAME 한국과학기술원 (KR) 2011-12-01 WO claimed
US-7521200-B2 Method for non-invasive rinse diagnosis and monitoring of periodontal diseases using colourimetric reagents GLOGAUER MICHAEL 2009-04-21 US claimed
US-20080085533-A1 Method and apparatus for non -invasive rinse diagnosis and monitoring of periodontal diseases GLOGAUER MICHAEL 2008-04-10 US claimed
US-5888787-A REACTING AROMATIC COMPOUND HAVING PENDANT METHYL GROUP, MEDIATOR, LACCASE IN PRESENCE OF OXYGEN TO OBTAIN CORRESPONDING ALDEHYDE NORTH CAROLINA STATE UNIVERSITY (US) 1999-03-30 US claimed
EP-0048347-B1 PROCESS AND REAGENT FOR THE DETERMINATION OF GLYCEROL Roche Diagnostics GmbH (DE) 1983-07-27 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260016452-A1 CHEMICAL HYDROGEN PEROXIDE INDICATOR MPO, SCO2, PPOX MAPT 4024/4885NPSR1 4813/4885ALDH1A1 1095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.